Omicron anxiety grips the White House

From: POLITICO Pulse - Wednesday Dec 22,2021 03:02 pm
Delivered daily by 10 a.m., Pulse examines the latest news in health care politics and policy.
Dec 22, 2021 View in browser
 
POLITICO's Pulse newsletter logo

By Adam Cancryn and Sarah Owermohle

With Carmen Paun

PROGRAMMING NOTE: Morning Pulse won’t publish from Friday, Dec. 24-Friday, Dec. 31. We’ll be back on our normal schedule on Monday, Jan. 3.

Editor’s Note: POLITICO Pulse is a free version of POLITICO Pro Health Care's morning newsletter, which is delivered to our s each morning at 6 a.m. The POLITICO Pro platform combines the news you need with tools you can use to take action on the day’s biggest stories. Act on the news with POLITICO Pro.

Quick Fix

— President Joe Biden is ending his first year in office the same way he began it: staring down a fierce resurgence of Covid-19.

— The legal battle over vaccine mandates has left hospitals and nursing homes navigating a patchwork of rules over whether and how to immunize their workers.

— The U.S. population grew at the slowest growth in the nation’s history in 2021 due largely to the pandemic’s impact.

WELCOME TO WEDNESDAY PULSE — where we’re calling false start, illegal motion and unsportsmanlike conduct on these NFL officials who cut the line at a testing site in New York. Send tips to acancryn@politico.com and sowermohle@politico.com.

Driving the Day

WE DON’T KNOW WHAT’S GOING TO HAPPEN FROM HERE’ — At the very least, Joe Biden deserves points for honesty.

With case counts exploding, testing wait times ticking up and hospitals bracing for a surge of new patients, Biden on Tuesday came out and just said it: “I don’t think anybody anticipated that this was going to be as rapidly spreading as it did.”

The admission — which came after his second Covid-focused speech in less than a month — reflects the degree to which Omicron has upended the White House’s best-laid plans, and further scrambled our perception of what was supposed to be a triumphant year in the battle against Covid-19.

The situation today is not nearly as bad as it was a year ago — that much is clear. Highly effective vaccines are widely available, masks and protective gear are plentiful, antiviral pills are right around the corner and the economy is open and on the upswing. When vaccinated people do get infected, they now rarely require hospitalization.

But things are also not as good as we’d hoped. Sure, schools are open — but quarantines and virtual learning are just a positive test away. Vaccines are free and easy to find — but those most at risk refuse to get them. The economy is humming — but fraught with battles over mandates and mask requirements.

And around every corner is still a sense of peril. Everyday life is riddled with anxieties tied to potential exposures and degrees of risk and, increasingly, the hunt for rapid tests. Omicron has magnified that, serving as a blunt reminder that the public health threat won’t be beholden to political cycles or broader public fatigue.

All that’s put Biden in a tough spot after a year in office. The president’s approval ratings are hitting fresh lows, he has dwindling tools at his disposal and polls show fewer people are even willing to listen to him amid hardening partisanship, POLITICO’s Joanne Kenen writes.

Even as Biden announced plans to give out 500 million free rapid tests — a widely popular idea — reporters and health experts were quick to point out it’d do little to make an immediate impact in the face of what will likely be a winter of record case infections (POLITICO’s David Lim broke it down best here).

Administration officials are clinging on to some hope, though: Early indications are that Omicron is less severe than its predecessors, booster shots are providing significant protection and there’s hope the resurgence will flame out quickly.

Yet even if we avert the worst, it’s clear the Covid-19 will be around far longer than the White House wanted — and a satisfying conclusion to the pandemic battle may already be out of reach.

“We don’t know what’s going to happen from here,” Biden said Tuesday of Omicron’s trajectory, a sentiment that could arguably be applied to the broader pandemic and the political fortunes tied to it. “We don’t know.”

HOSPITALS IN LIMBO WITH VAX MANDATE BRAWL — With Omicron cases surging and health workers in short supply, hospitals and nursing homes are grappling with a patchwork of rules for vaccinating their staff against Covid-19 — and in some cases, begging off immunization requirements the Biden administration expects to start enforcing on Jan. 4.

Court challenges brought by mostly Republican states have frozen the administration’s vaccine mandates for health workers in half of the states, upsetting an already delicate balance between patient safety and pandemic readiness as health facilities brace for a wintertime surge of cases, POLITICO’s Rachael Levy writes.

That’s left federal regulators in a thorny position. The Centers for Medicare and Medicaid Services could follow through on Biden’s requirement with CMS-funded providers but will likely face its own legal battles. The trade group for nursing home operators, for instance, is urging the administration to go slow because of the legal uncertainty, while a major hospital trade group isn’t expecting a resolution for weeks to come.

The standoff will likely drag into the new year, possibly until the Supreme Court weighs in on the mandate’s constitutionality. One lobbyist said CMS lawyers have urged leadership to abandon the scheduled enforcement plans, including those in states where the mandate can take effect. Meanwhile, the Department of Justice asked justices last week to let the mandate go forward.

 

STEP INSIDE THE WEST WING: What's really happening in West Wing offices? Find out who's up, who's down, and who really has the president’s ear in our West Wing Playbook newsletter, the insider's guide to the Biden White House and Cabinet. For buzzy nuggets and details that you won't find anywhere else, subscribe today.

 
 
Coronavirus

COVID CRUSHES US POPULATION GROWTHThe U.S. population is growing at the slowest rate since the nation’s founding — a historic deceleration driven largely by the pandemic’s effects, POLITICO’s Claire Rafford writes.

The 0.1 percent growth rate in 2021 means this is also the first year since 1937 that the overall population increased by fewer than 1 million people, according to Census Bureau data.

The U.S.’s growth has slowed in recent years owing to declining birth and migration rates, coupled with a rise in death rates due to an aging population. Covid-19 has exacerbated the impact of those factors, the agency said.

WHO BACKS NOVAVAX VACCINE — The World Health Organization is granting Novavax’s Covid-19 vaccine an emergency use listing following the shot’s endorsement by the European Medicines Agency, POLITICO’s Carmen Paun reports.

The vaccine proved 90 percent effective against Covid-19 in the U.K. when the Alpha variant was dominant and could provide needed supply for the global vaccination campaign. But it’s still unclear how it will perform against Omicron, which has spread throughout much of Europe and the U.S. over the last few weeks.

The WHO had previously authorized Covovax, a version of Novavax’s vaccine produced by the Serum Institute of India.

NEW MAYOR, NEW MANDATES FOR BOSTONBoston Mayor Michelle Wu will require proof of vaccination for staff and patrons at restaurants, bars and gyms in 2022 — and also plans to mandate that city employees be vaccinated, POLITICO’s Lisa Kashinsky reports.

The strict requirements come as Covid-19 cases climb in Boston and across the country. They represent the latest test of whether businesses and voters will accept broad vaccination directives.

Republicans in the city are already pushing back on the new rules, and the reception within the business community has been mixed. A group representing medical technicians, firefighters and police is already threatening to sue.

But Wu — who took office in November — has cast the mandates as critical to slowing the virus’ spread, lamenting that the new requirements couldn’t be put into place faster. Several mayors of eastern Massachusetts cities have also since vowed to follow suit with their own policies requiring vaccinations.

Vaccines

OXFAM FILES SEC COMPLAINT AGAINST MODERNAOxfam America has filed a complaint with the Securities and Exchange Commission alleging that Moderna failed to disclose it was in a patent dispute with the National Institutes of Health over its Covid-19 vaccine, Carmen writes.

A global justice nonprofit and Moderna shareholder that has urged the company to provide more aid to the global vaccination effort, Oxfam accused the company of not being transparent with its investors and burying critical information about the dispute.

Moderna recently halted its dispute with the NIH — which dates as far back as last year — in hopes of finding an amicable solution. The company didn’t respond to a request for comment about Oxfam’s complaint.

Names in the News

Jon Selib will join investment firm Clayton, Dubilier & Rice as its managing director and global external affairs leader in March. He was previously Pfizer’s senior vice president of global policy and public affairs.

 

BECOME A GLOBAL INSIDER: The world is more connected than ever. It has never been more essential to identify, unpack and analyze important news, trends and decisions shaping our future — and we’ve got you covered! Every Monday, Wednesday and Friday, Global Insider author Ryan Heath navigates the global news maze and connects you to power players and events changing our world. Don’t miss out on this influential global community. Subscribe now.

 
 
What We're Reading

Private equity groups like Dorilton Capital are buying up hospice care chains, a surge that’s bringing mysterious management and ownership into the business of dying, HuffPost’s Molly Redden writes.

Johnson & Johnson and the Food and Drug Administration downplayed the risks posed by aerosol sunscreens made with known carcinogen benzene, but an FDA report recently made public exposes the dangers, Consumer Reports’ Ryan Felton writes.

Hospitals nationwide are scrambling to secure effective monoclonal antibody treatments as two in three appear ineffective against the Omicron variant, The New York Times’ Christina Jewett, Carl Zimmer and Rebecca Robbins report.

 

Follow us on Twitter

Adriel Bettelheim @abettel

Sara Smith @sarasmarley

Adam Cancryn @adamcancryn

Tucker Doherty @tucker_doherty

Dan Goldberg @dancgoldberg

David Lim @davidalim

Alice Miranda Ollstein @aliceollstein

Sarah Owermohle @owermohle

Carmen Paun @carmenpaun

Darius Tahir @dariustahir

Erin Banco @ErinBanco

Lauren Gardner @Gardner_LM

Katherine Ellen Foley @katherineefoley

Ben Leonard @_BenLeonard_

Megan R. Wilson @misswilson

 

Follow us

Follow us on Facebook Follow us on Twitter Follow us on Instagram Listen on Apple Podcast
 

To change your alert settings, please log in at https://www.politico.com/_login?base=https%3A%2F%2Fwww.politico.com/settings

This email was sent to by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

Please click here and follow the steps to .

More emails from POLITICO Pulse

Dec 14,2021 03:02 pm - Tuesday

Califf goes to Congress

Dec 13,2021 03:02 pm - Monday

The pandemic news that hit home